Silicon Laboratories Inc. (NASDAQ:SLAB – Get Free Report) CEO Robert Matthew Johnson sold 5,879 shares of the firm’s stock in a transaction on Friday, May 16th. The shares were sold at an average price of $131.20, for a total transaction of $771,324.80. Following the transaction, the chief executive officer now directly owns 73,688 shares of the company’s stock, valued at $9,667,865.60. The trade was a 7.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
Silicon Laboratories Trading Down 2.4%
Shares of SLAB stock traded down $3.09 during trading hours on Monday, hitting $128.07. The company’s stock had a trading volume of 189,833 shares, compared to its average volume of 335,993. The company has a 50 day moving average of $108.72 and a 200 day moving average of $121.21. Silicon Laboratories Inc. has a 12-month low of $82.82 and a 12-month high of $160.00. The stock has a market cap of $4.17 billion, a PE ratio of -21.56 and a beta of 1.36.
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.01. The firm had revenue of $177.71 million for the quarter, compared to the consensus estimate of $177.48 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The firm’s quarterly revenue was up 67.0% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.92) earnings per share. As a group, analysts anticipate that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Read Our Latest Analysis on SLAB
Hedge Funds Weigh In On Silicon Laboratories
A number of large investors have recently added to or reduced their stakes in SLAB. Barclays PLC raised its position in Silicon Laboratories by 23.4% during the third quarter. Barclays PLC now owns 70,568 shares of the semiconductor company’s stock worth $8,157,000 after acquiring an additional 13,363 shares during the period. Park Avenue Securities LLC acquired a new position in Silicon Laboratories during the fourth quarter worth $268,000. Procyon Advisors LLC raised its position in Silicon Laboratories by 4.4% during the fourth quarter. Procyon Advisors LLC now owns 3,176 shares of the semiconductor company’s stock worth $395,000 after acquiring an additional 133 shares during the period. Arkadios Wealth Advisors acquired a new position in Silicon Laboratories during the fourth quarter worth $237,000. Finally, Nisa Investment Advisors LLC raised its position in Silicon Laboratories by 6.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,134 shares of the semiconductor company’s stock worth $514,000 after acquiring an additional 240 shares during the period.
About Silicon Laboratories
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also
- Five stocks we like better than Silicon Laboratories
- Russell 2000 Index, How Investors Use it For Profitable Trading
- What Ray Dalio’s Latest Moves Tell Investors
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
- Stock Analyst Ratings and Canadian Analyst Ratings
- Qualcomm: This Week Could Make or Break the Rally
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.